HOME >> BIOLOGY >> NEWS
Premature births from inflammation and infection rapidly detected by proteomics technology

A combination of four proteins that result from inflammation and infection and lead to premature birth can be rapidly and accurately detected in the amniotic fluid of pregnant women using proteomics technology, Yale researchers report in two studies in the February issue of British Journal of Obstetrics and Gynecology.

Using proteomics science, the Yale team, in collaboration with two other academic institutions, developed a novel method called MR scoring to discriminate healthy from diseased women in whom preterm delivery is impending and the health of the fetus is in danger. MR scoring relies on identification of a group of proteins that serve as biomarkers characteristic to women who will deliver preterm. The proteins detected are Human neutrophil defensin 1, Human neutrophil defensin 2, Calgranulin C and Calgranulin A.

"We are probably at a turning point in the history of preterm labor diagnosis," said Irina Buhimschi, M.D., research scientist in the Department of Obstetrics & Gynecology and Reproductive Sciences. "While many proteins are present in the amniotic fluid, not all are biomarkers with diagnostic significance."

About 50 percent of women who deliver prematurely have evidence of inflammation in the amniotic fluid. In the current study, Buhimschi and co-authors analyzed stored samples of amniotic fluid from 107 women, some diagnosed with rupture of the membranes or twins and eventually delivered prematurely. The sensitivity and specificity of the MR score in identifying women who had infection and inflammation and delivered earlier reached 100 percent. The four biomarkers are necessary and sufficient to separate between sick and healthy patients.

Buhimschi said the current "gold standard" for infection consists of amniotic fluid culture, which takes days to obtain results. A proteomic diagnostic test for infection and inflammation could probably be performed much faster than the current available laboratory tests. Other cu
'"/>

Contact: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University
4-Feb-2005


Page: 1 2

Related biology news :

1. Premature births may be linked to seasonal levels of pesticides and nitrates in surface water
2. Noninvasive screening in early pregnancy reduces Downs births by 50 percent
3. Rapid syphilis testing in Haiti will prevent congenital disease and stillbirths
4. Difficult births in obese women due to uterus failure
5. Pitt study notes decline in male births in the US and Japan
6. Improving outcomes in premature births
7. African-Americans at increased risk for earlier preterm births
8. Ozone levels may raise risk of underweight births
9. New research on mulitple vs single births may offer new approaches for infertility
10. Penn researchers discover how key protein stops inflammation
11. Gene variations directly link inflammation to an increased risk for lung cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... August 05, 2020 , ... Regenative Labs has received approval ... CoreText™ and ProText™, making them the first Wharton’s jelly allografts to be assigned a ... The company’s solutions are the first Wharton’s jelly allograft product to be recognized as ...
(Date:7/18/2020)... (PRWEB) , ... July 16, 2020 , ... ... that demonstrates the effectiveness of the Invictus Medical Neoasis™ active noise control device ... The study reported that the Neoasis™ device attenuated the alarm sounds from patient ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio ... findings of Neihulizumab, a biologic for the treatment of steroid-refractory acute graft-versus-host disease ... hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson Cancer Research Center, this ...
Breaking Biology News(10 mins):
(Date:8/15/2020)... , ... August 13, 2020 , ... True Terpenes ... creation of its Scientific Advisory Board (SAB) to research the medical potential of terpenes ... be enhanced when combined with terpenes. The board is focused on expanding the recently ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... firm, is making available for free its new white paper – Simulated ... simulation testing into today’s biologics licensing application (BLA). In response, Modality Solutions ...
(Date:8/3/2020)... ... August 03, 2020 , ... ... Jim Corrigan, President and CEO has been named one of the 100 most ... industry sectors, PharmaVoice 100 honorees are selected based on how they have inspired ...
(Date:7/31/2020)... ... July 29, 2020 , ... G-CON ... of its new tagline, “BUILDING FOR LIFE.” The adoption of this taglines comes ... globe, requiring fast track capacity to provide patients with urgently needed vaccines and ...
Breaking Biology Technology:
Cached News: